An AllTrials project

NCT03384966: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT03384966
Title A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Jan. 24, 2018
Completion date Aug. 18, 2018
Required reporting date Aug. 18, 2021, midnight
Actual reporting date April 23, 2021
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None